Want to see AU:WNX full AI Analyst Report?
WNX Stock Chart & Stats
AU$0.09
AU$0.01(1.47%)
At close: 4:00 PM EST
AU$0.09
AU$0.01(1.47%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.28
Previous CloseN/A
Volume2.27K
Average Volume (3M)51.95K
Market Cap
AU$4.09M
Enterprise ValueAU$12.64M
Total Cash (Recent Filing)AU$975.00K
Total Debt (Recent Filing)AU$10.03M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding73,026,810
10 Day Avg. Volume31,968
30 Day Avg. Volume51,946
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$48.60M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageA debt-to-equity of ~0.48 and a healthy equity ratio indicate the company has moderate leverage and room to fund operations or invest without excessive financial strain. Over 2-6 months this supports resilience to shocks and optionality for modest growth or restructuring initiatives.
Modest Revenue GrowthSustained revenue growth near mid-single-digits signals demand for the company’s consumer health products and underlying market traction. Over several months this trend supports incremental scale, potential margin improvement with fixed-cost absorption, and validates the brand/distribution model.
Positive Gross MarginA positive gross margin shows the core product economics allow coverage of direct costs and a base for operating margin recovery if SG&A and overhead are controlled. This durable structural feature makes profitability achievable with revenue scaling or cost discipline.
Bears Say
Negative Cash FlowPersistent negative operating and free cash flows constrain the company’s ability to self-fund working capital, marketing, or new product investment. Over the medium term this raises reliance on external financing, increases execution risk, and can limit strategic flexibility.
Negative ROEA negative ROE reflects that capital employed is not delivering shareholder returns, implying structural profitability issues or inefficient capital deployment. Over months this hampers investor confidence, reduces reinvestment capacity, and signals need for remediation of operations or capital structure.
Loss-making OperationsNegative net profit and EBIT margins show the business currently loses money on core operations, implying unit economics or overheads are misaligned with pricing and volume. Without sustained margin improvement, losses will persist and undermine long-term viability and scaling prospects.
Wellnex Life Ltd News
WNX FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest share price was AU$0.04 and its highest was AU$0.28 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is AU$4.09M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 23 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Feb 26, 2026. The company reported -AU$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.026.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 73,026,810 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -AU$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in AU:WNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:WNX Sentiment 100%
Sector Average 60%
Sector Average 60%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.14%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-17.21%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Technical Analysis
―
Bubs Australia Ltd.
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―